Peer Review History
| Original SubmissionSeptember 13, 2025 |
|---|
|
Dear Dr. LI, Please submit your revised manuscript by Nov 26 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Muhammad Abdul Rehman Rashid, PhD Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. PLOS ONE now requires that authors provide the original uncropped and unadjusted images underlying all blot or gel results reported in a submission’s figures or Supporting Information files. This policy and the journal’s other requirements for blot/gel reporting and figure preparation are described in detail at https://journals.plos.org/plosone/s/figures#loc-blot-and-gel-reporting-requirements and https://journals.plos.org/plosone/s/figures#loc-preparing-figures-from-image-files. When you submit your revised manuscript, please ensure that your figures adhere fully to these guidelines and provide the original underlying images for all blot or gel data reported in your submission. See the following link for instructions on providing the original image data: https://journals.plos.org/plosone/s/figures#loc-original-images-for-blots-and-gels. In your cover letter, please note whether your blot/gel image data are in Supporting Information or posted at a public data repository, provide the repository URL if relevant, and provide specific details as to which raw blot/gel images, if any, are not available. Email us at plosone@plos.org if you have any questions. 3. PLOS requires an ORCID iD for the corresponding author in Editorial Manager on papers submitted after December 6th, 2016. Please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field. This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager. 4. We note that the grant information you provided in the ‘Funding Information’ and ‘Financial Disclosure’ sections do not match. When you resubmit, please ensure that you provide the correct grant numbers for the awards you received for your study in the ‘Funding Information’ section. 5. Thank you for stating the following financial disclosure: This study was supported by the General Project of Shaanxi Provincial Key R&D Program (2024JC-YBQN0224) , Key Laboratory Project of Scientific Research Program of Shaanxi Provincial Department of Education (23JS069), Yulin City Science and Technology Plan Project (2024-CXY-131), Doctoral Scientific Research Start-up Fund Project of Yulin University (2023GK11), Innovation Team Project for High-efficiency Cultivation and Value-added Development of Ecological Mulberry in Northern Shaanxi (2025RS-CXTD-038), Key Special Project of Shaanxi Forestry Science and Technology Innovation (SXLK2023-02-36), Project of Yulin Municipal Bureau of Science and Technology (2023-CXY-171). Please state what role the funders took in the study. If the funders had no role, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript." If this statement is not correct you must amend it as needed. Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf. 6. Thank you for stating the following in the Acknowledgments Section of your manuscript: This study was supported by the General Project of Shaanxi Provincial Key R&D Program (2024JC-YBQN0224) , Key Laboratory Project of Scientific Research Program of Shaanxi Provincial Department of Education (23JS069), Yulin City Science and Technology Plan Project (2024-CXY-131), Doctoral Scientific Research Start-up Fund Project of Yulin University (2023GK11), Innovation Team Project for High-efficiency Cultivation and Value-added Development of Ecological Mulberry in Northern Shaanxi (2025RS-CXTD-038), Key Special Project of Shaanxi Forestry Science and Technology Innovation (SXLK2023-02-36), Project of Yulin Municipal Bureau of Science and Technology (2023-CXY-171). We note that you have provided funding information that is not currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form. Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows: This study was supported by the General Project of Shaanxi Provincial Key R&D Program (2024JC-YBQN0224) , Key Laboratory Project of Scientific Research Program of Shaanxi Provincial Department of Education (23JS069), Yulin City Science and Technology Plan Project (2024-CXY-131), Doctoral Scientific Research Start-up Fund Project of Yulin University (2023GK11), Innovation Team Project for High-efficiency Cultivation and Value-added Development of Ecological Mulberry in Northern Shaanxi (2025RS-CXTD-038), Key Special Project of Shaanxi Forestry Science and Technology Innovation (SXLK2023-02-36), Project of Yulin Municipal Bureau of Science and Technology (2023-CXY-171). Please include your amended statements within your cover letter; we will change the online submission form on your behalf. 7. When completing the data availability statement of the submission form, you indicated that you will make your data available on acceptance. We strongly recommend all authors decide on a data sharing plan before acceptance, as the process can be lengthy and hold up publication timelines. Please note that, though access restrictions are acceptable now, your entire data will need to be made freely accessible if your manuscript is accepted for publication. This policy applies to all data except where public deposition would breach compliance with the protocol approved by your research ethics board. If you are unable to adhere to our open data policy, please kindly revise your statement to explain your reasoning and we will seek the editor's input on an exemption. Please be assured that, once you have provided your new statement, the assessment of your exemption will not hold up the peer review process. 8. We notice that your supplementary table is included in the manuscript file. Please remove them and upload them with the file type 'Supporting Information'. Please ensure that each Supporting Information file has a legend listed in the manuscript after the references list. 9. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information. 10. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? Reviewer #1: Yes Reviewer #2: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: I Don't Know Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: No Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #2: No ********** Reviewer #1: The manuscript “Development of inDel markers associated with leaf protein content in mulberry based on whole-genome resequencing” provided detailed sufficient information. However, some clarification needs to be clear: 1. The author requested to provide genome size information of the studied accessions, which is highly correlated with InDels. 2. Why only M. alba? Needs to be compared with other species. 3. Methodology needs to improve significantly. There are several gaps, and quantified information is lacking. 4. Detailed information of the aligned white mulberry reference genome is essential for reproducibility. 5. Average coverage depth reached is very low (16×); however, genome coverage was 87.67%. need to be supplemented with detailed statistics. 6. Incomplete genome coverage is biased, particularly for non-mammalian species for which fewer KEGG pathways (KO) are defined. Other methods need to be explored. 7. Because of low resolution of the figs, unable to read and verify the statement “The marker demonstrated 87% phenotypic concordance (r=0.726, P<0.01), with specificity rates of 83.33% in high-protein accessions and 90.9% in low-protein accessions.” 8. Quantified results are lacking because the low resolution is unable to highlight the points. 9. In discussion, more recent studies on indels/repeatomes of different Morus spp. need to be discussed to address the studies' significance. 10. The abstract and conclusion are just like mirrors and need to be rewritten. Reviewer #2: Dear editor The manuscript entitled “Development of InDel markers associated with leaf protein content in mulberry based on whole-genome resequencing” addresses a very interesting and important trait in mulberry — leaf protein content. Since mulberry is well known as a protein-rich plant and serves as the sole feed for silkworms, leaf protein content is a key determinant for silk production. However, several aspects of the study require clarification to strengthen the reliability of the conclusions. Additionally, the manuscript contains many formatting and language issues that should be carefully corrected. Major Comments Figure 7: There are two bands observed for the low-protein-content accessions and one band for the high-protein-content accessions. Why? One would expect a single band for homozygotes. It is notable that the low-protein accessions share a band with the same migration position as the high-protein ones. Are the low-protein-content accessions heterozygotes? Surprisingly, no homozygotes are observed. It is essential to sequence these bands and design another pair of primers in the nearby region to exclude false positives or amplification of homologous genes elsewhere in the genome. Selection of Accessions: The crude protein content ranges from 11.25% to 28.68%. Why were the accessions with the highest and lowest protein contents not selected as extreme phenotypes? Please clarify the principle or criteria underlying the algorithm or method used for selecting the accessions. Primer Design and Validation: A total of 36 primer pairs were designed, yet only one locus (Chr1-3-204) is presented. What about the others? Please provide statistical summaries or validation results for all designed primers to support the robustness of the marker development. Functional Association: Which gene is associated with the locus Chr1-3-204? Why is this gene hypothesized to be related to leaf protein content? It would greatly strengthen the manuscript if functional validation — e.g., through genetic modification or functional assays in mulberry or model plants — could be proposed or discussed. Minor Comments Remove unnecessary spaces at the beginning of each paragraph. Line 141: “The Flollowing” → should be corrected to “The following.” Line 171: “ddH2O” → the “2” should be formatted as a subscript (H₂O). Please check and correct this format throughout the manuscript. Line 190: “The The leaf protein” → remove the duplicate “The.” Line 190: “materials” → consider changing to “accessions.” Line 219: The bracket format is inconsistent with other citations; please standardize. Improve the quality of all figures — the fonts are too small, and the resolution is low. Figure 1: Lacks labels for the x- and y-axes; please add them. Figure 2: Font size is too small; increase for readability. Figure Legends: Should be more detailed and self-explanatory. For Figure 7, please define abbreviations (e.g., “H” for high-protein-content accessions and “L” for low-protein-content accessions). ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: No Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
Development of InDel markers associated with leaf protein content in mulberry based on whole-genome resequencing PONE-D-25-49532R1 Dear Dr. LI, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support . If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Muhammad Abdul Rehman Rashid, PhD Academic Editor PLOS One Reviewers' comments: Reviewer's Responses to Questions Comments to the Author Reviewer #2: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions??> Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #2: Yes ********** Reviewer #2: (No Response) ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #2: No ********** |
| Formally Accepted |
|
PONE-D-25-49532R1 PLOS One Dear Dr. LI, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS One. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Muhammad Abdul Rehman Rashid Academic Editor PLOS One |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .